 |
Glatiramer acetate for injection |
|---|---|
| Trade Name | Copaxone |
| Orphan Indication | Primary-progressive multiple sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2001-06-05 00:00:00 |
| Sponsor | Teva Pharmaceuticals USA;1090 Horsham Road;North Wales, Pennsylvania, 19454 |
